Trials / Completed
CompletedNCT00630357
Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy
A Phase IV, Open-label, Multi-center Trial to Evaluate the Safety and Efficacy of Keppra® After Conversion to Mono-therapy in Adult Subjects With Partial Epilepsy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
A cohort of patients who became seizure-free during add-on treatment to one standard AED with Keppra in a previous trial (N01031) were followed to assess whether seizure freedom was maintained. Tolerability was documented.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam (Keppra) |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2008-03-07
- Last updated
- 2013-11-15
Source: ClinicalTrials.gov record NCT00630357. Inclusion in this directory is not an endorsement.